U-Systems raises $16.5m in funding:
This article was originally published in Clinica
Executive Summary
Developer of automated breast ultrasound systems U-Systems (San Jose, California) has raised an additional $16.5m in a series D financing round, bringing total funding to $44.5m. The new round, led by Siemens Venture Capital, enables U-Systems to expand sales and marketing of its FDA-cleared and CE-marked SomoVu automated breast ultrasound system, and continue investing in product development. Existing investors Sycamore Venture Capital, MDS Capital, Radius Ventures, Kinetic Capital and United Investments contributed to the round, as did new shareholders President International Development Corporation, iD Innovation, China Investment & Development Company and TSC Bioventures.
You may also be interested in...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.